Your browser doesn't support javascript.
loading
Biguanides drugs: Past success stories and promising future for drug discovery.
Grytsai, Oleksandr; Myrgorodska, Iuliia; Rocchi, Stéphane; Ronco, Cyril; Benhida, Rachid.
Affiliation
  • Grytsai O; Université Côte d'Azur, CNRS, Institut de Chimie de Nice UMR 7272, 28 Avenue Valrose, 06108, Nice, France; Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, SK10 4TG, United Kingdom.
  • Myrgorodska I; Université Côte d'Azur, CNRS, Institut de Chimie de Nice UMR 7272, 28 Avenue Valrose, 06108, Nice, France.
  • Rocchi S; Université Côte d'Azur, INSERM U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Bâtiment ARCHIMED, 151 route de Saint Antoine de Ginestière, 06204, Nice cedex 3, France.
  • Ronco C; Université Côte d'Azur, CNRS, Institut de Chimie de Nice UMR 7272, 28 Avenue Valrose, 06108, Nice, France. Electronic address: cyril.ronco@univ-cotedazur.fr.
  • Benhida R; Université Côte d'Azur, CNRS, Institut de Chimie de Nice UMR 7272, 28 Avenue Valrose, 06108, Nice, France; Department of Chemical and Biochemical Sciences, Green Process Engineering, CBS, Mohamed VI Polytechnic University, UM6P, 43150 Ben Guerir, Morocco.
Eur J Med Chem ; 224: 113726, 2021 Nov 15.
Article in En | MEDLINE | ID: mdl-34364161
ABSTRACT
Biguanides have attracted much attention a century ago and showed resurgent interest in recent years after a long period of dormancy. They constitute an important class of therapeutic agents suitable for the treatment of a wide spectrum of diseases. Therapeutic indications of biguanides include antidiabetic, antimalarial, antiviral, antiplaque, and bactericidal applications. This review presents an extensive overview of the biological activity of biguanides and different mechanisms of action of currently marketed biguanide-containing drugs, as well as their pharmacological properties when applicable. We highlight the recent developments in research on biguanide compounds, with a primary focus on studies on metformin in the field of oncology. We aim to provide a critical overview of all main bioactive biguanide compounds and discuss future perspectives for the design of new drugs based on the biguanide fragment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biguanides / Drug Discovery / Hypoglycemic Agents Limits: Humans Language: En Journal: Eur J Med Chem Year: 2021 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biguanides / Drug Discovery / Hypoglycemic Agents Limits: Humans Language: En Journal: Eur J Med Chem Year: 2021 Document type: Article Affiliation country: United kingdom